Vicente AI, Luna I, Ruiz JC, Remigia MJ, Jerez A, Lluch R, Llopis I, Marco MJ, Benet C, Alonso C, Linares MD, Serrano L, Orero MT, Ortuno FJ, Senent ML. WHO/ICC Classification for Myelodysplastic Neoplasms/Syndromes Performs Better for Subtype Cytomorphological Diagnosis? Diagnostics (Basel). 2024 Jul 29;14(15):1631. doi: 10.3390/diagnostics14151631. PubMed PMID: 39125507; PubMed Central PMCID: PMC11312140.
AÑO: 2024; IF: 3.0
|
Rodenas-Quinonero I, Chen-Liang T, Martin-Santos T, Salar A, Fernandez-Gonzalez M, Celades C, Navarro JT, Martinez-Garcia AB, Andreu R, Balaguer A, Martin Garcia-Sancho A, Baile M, Lopez-Jimenez J, Marquet-Palomanes J, Teruel AI, Terol MJ, Benet C, Frutos L, Navarro JL, Una J, Suarez M, Cortes M, Contreras J, Ruiz C, Tamayo P, Mucientes J, Sopena-Novales P, Reguilon-Gallego L, Sanchez-Blanco JJ, Perez-Ceballos E, Jerez A, Ortuno FJ. Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation-Wide cohort study. Cancer Med. 2023 Mar;12(6):6536-6546. doi: 10.1002/cam4.5424. Epub 2022 Nov 13. PubMed PMID: 36373169; PubMed Central PMCID: PMC10067085.
AÑO: 2023; IF: 2.9
|
Carrillo-Tornel S, Chen-Liang TH, Zurdo M, Puiggros A, Gomez-Llonin A, Garcia-Malo MD, Cuenca-Zamora EJ, Ortuno FJ, Lopez AMH, Espinet B, Jerez A. NOTCH1 mutation in chronic lymphocytic leukaemia is associated with an enhanced cell cycle G1/S transition and specific cyclin overexpression: Preclinical ground for targeted inhibition. Br J Haematol. 2023 May;201(3):470-479. doi: 10.1111/bjh.18609. Epub 2022 Dec 27. PubMed PMID: 36573331.
AÑO: 2023; IF: 5.1
|
Soler-Espejo E, Marco-Ayala J, Chen-Liang TH, Lopez-Poveda MJ, Teruel-Montoya R, Ortuno FJ. CD5+ follicular lymphoma rapidly transformed to high-grade B-cell lymphoma with double-hit: from BCL2 to MYC disruption. Blood Res. 2023 Mar 31;58(1):79-82. doi: 10.5045/br.2023.2023039. No abstract available. PubMed PMID: 36987619; PubMed Central PMCID: PMC10063588.
AÑO: 2023; IF: 2.2
|